Come and join us to meet the leading experts of the field participating in the panel discussion and sessions!
Thursday 30.3.2023
08:45 – 9:30 Registration and coffee
9:30 – 9:40 Opening words
9:40 – 11:00 Session 1: Epidemiology (8 min + 2 min for Q&A)
Eili Huhtamo: Sindbis and other mosquito borne viruses in Finland: past, present and future
Ushanandini Mohanraj: Significant association with high prevalence and activity of cutavirus in parapsoriasis skin
Jenni Virtanen: Epidemiology, characterization, and diagnostics of equine pastern dermatitis and parapoxvirus
Lorna Culverwell: Characterisation of the RNA Virome of Nine Ochlerotatus Species in Finland
Olli Vapalahti: Molecular epidemiology of introduction and spread of emerging viruses, Finland (13 min + 2 min for Q&A)
11:00 – 12.00 Session 2: Vaccines (8 min + 2 min for Q&A)
Timo Vesikari: New 3-antigen hepatitis B vaccine: High immune response rate and good persistence of anti-HBs antibodies compared with conventional hepatitis B vaccine in adults (13 min + 2 min for Q&A)
Vesa Hytönen: Display of antigens on virus-like particles
Vili Lampinen: SpyCatcher-mediated influenza M2e peptide display is more immunogenic than direct genetic fusion on the norovirus-like particle
Miao Jiang: COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs
Arttu Reinholm: COVID-19 vaccinated health care workers show relatively high rate of breakthrough infections and reduced neutralizing antibody activity against multiple Omicron variants and subvariants
12:00 – 13:00 Lunch (restaurant)
13:00 – 14:00 Session 3: Vaccine development in Finland
Arto Palmu: Update of Finnish Vaccine Research FVR
Kalle Saksela: Update of Finnish coronavirus vaccine
Heikki Hyöty: Update of Research Center for Vaccine Development and Immunology VACCIM
14:00 – 15:00 Paneelikeskustelu “Mitä opimme koronaviruspandemiasta?”
Carita Savolainen-Kopra, Mika Rämet, Ilkka Julkunen, Kalle Saksela, Olli Vapalahti
15:00 – Coffee (exhibition area)
15:20 – 16:15 Pitch talk session 1 (exhibition area) (3 min + 1 min for Q&A)
Milja Belik: T cell responses to SARS-CoV-2 variants in thrice COVID-19 mRNA vaccinated health care workers
Phuoc Truong Nguyen: Virus-host interactions and prediction of putative hosts in Flavivirus and Coronaviridae
Pinja Jalkanen: T cell responses following COVID-19 vaccination in primary immunodeficiency patients
Oona Liedes: Declined Omicron infection-induced hybrid immunity against Omicron subvariants BQ.1.1, XBB.1 and XBB.1.5
Leo Hannolainen: Reactivation of chromosomally integrated HHV-6 in a solid transplant recipient
Lari Pyöriä: Genomic landscape of human tissue-resident DNA virome
Sally Chesnut: Identifying acute human protoparvovirus infections
Tatiana Demina: Viral diversity in Antarctic sea ice
Ankita Gupta: Presence of Porcine Noroviruses in Finnish Pigs
Katja Lind: Performance of dried real-time PCR reagents for influenza A virus detection
16:15 – 17:00 Session 4: Diagnostics (8 min + 2 min for Q&A)
Niko Tervo: Integration and perspectives of NGS in a public health laboratory
Maria Perdomo: Unmasking the eukaryotic DNA virome
Eeva Auvinen: HPV self-sampling in cervical cancer screening
Pekka Kolehmainen: Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers
17:00 – 18:30 Free-time
18:30 – 19:30 Pitch talk session 2 (exhibition area) (3 min + 1 min for Q&A)
Ausra Domanska: Molecular Organisation of Tick-Borne Encephalitis Virus
Fanny Frejborg: Characteristics and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1
Jussi Palomäki: Attenuated replication competent HSV expressing Has2 gene of naked mole rat shows enhanced oncolytic effect in glioblastoma and colon carcinoma cells
Ashwini Kedari: Insight into rabies virus neutralization revealed by an engineered antibody scaffold
Sergei Gurianov: Crystal structure of Parechovirus A 3Dpol RNA-dependent RNA polymerase
Satu Hakanen: Prelytic nuclear egress of progeny parvovirus capsids
Rupesh Balaji Jayachandran: Structural analysis of sars-cov-2 neutralization by a spike-targeting patient-derived monoclonal antibody
Liina Hannula: Structural basis for SARS-CoV-2 neutralization by small inhibitor protein TriSb92
Vinaya Venkat: Understanding SARS-CoV-2 transmission, infection and susceptibility in Neovison vison
Larissa Laine: The cross-species role of coronavirus nucleocapsid protein in innate immune evasion and its effect on viral replication
Zlatka Plavec: Structural Studies Reveal that Endosomal Cations Promote Formation of Infectious Coxsackievirus A9 A-Particles, Facilitating RNA and VP4 Release
Maija Suvanto: Characterization of two orbiviruses isolated from Finnish Ochlerotatus communis mosquitoes
Marika Skön: A comparison of the IFN responses induced by seasonal and avian influenza viruses in human moDCs
Jutta Laiho: HEDIMED, Human Exposomic Determinants of Immune Mediated Diseases
19:30 – Dinner and other evening activities
Friday 31.3.2023
8:00 – 9:30 Session 5: Antivirals and treatments (8 min + 2 min for Q&A)
Päivi Ojala: SOX18 transcription factor as an attractive molecular target for Kaposi’s sarcoma, a viral cancer
Kiira Kalke: Antiviral UL29-targeted siRNA swarms in treatment of HSV-1 infection
Dhanik Reshamwala: Polyphenols Epigallocatechin Gallate and Resveratrol, and Polyphenol-Functionalized Nanoparticles Prevent Enterovirus Infection through Clustering and Stabilization of the Viruses
Leonóra Szirovicza: Characterization and molecular biology of Daletvirus boae – a founding member of the realm Ribozyviria
Aditya Thiruvaiyaru: Host factors essential for efficient alphavirus replication
Sailee Shroff: Resin-functionalized plastic surface kills infectivity of Human Coronaviruses
Tania Quirin: The human nasal epithelium in vitro to study respiratory viral infections
Emil Loikkanen: Inactivation of hepatitis E -virus (HEV) and its surrogate virus murine norovirus (MNV) during industrial cold smoking process.
9:30 – 10:30 My life, my viruses – Senior virologists’ speeches
Veijo Hukkanen, Klaus Hedman
10:30 – Coffee (exhibition area)
10:50 – 11.30 Pitch talk session 3 (exhibition area) (3 min + 1 min for Q&A)
Petri Susi: Cell infectivity and genome profiles of echovirus 7 isolates and Rigvir® oncolytic virotherapy virus
Elina Väisänen: Infectious viruses from transfected SARS-CoV-2 genomic RNA
Kyrylo Bisikalo: Studying TBEV using BSL2 model – rLGTV
Sari Maljanen: Full Steam Ahead
Hanna Oksanen: State-of-the-art research services and resources by ISIDORe to study viruses and epidemic-prone pathogens
Visa Ruokolainen: Exploring nuclear details of herpesvirus infection using expansion microscopy
11:30 – 12:30 Session 6: Pathogenesis (8 min + 2 min for Q&A)
Anni Honkimaa: JC polyomavirus modifies the expression of crucial human microRNAs in PML brain
Moona Huttunen: Vaccinia virus hijacks ESCRT-mediated multivesicular body formation for virus egress
Salla Mattola: Parvovirus infection alters the nucleolar organization
Ravi Ojha: Multiple endocytic mechanisms mediate SARS-CoV-2 cell entry and infection
Maria Anastasina: Tick-Borne Encephalitis Virus Maturation
12:30 – 13:15 Lunch (exhibition area)
13:15 – 15:00 Session 7: Virus and host (8 min + 2 min for Q&A)
Ilkka Julkunen: Mammalian Filovirus VP24 matrix proteins downregulate innate immune response by inhibiting the interferon induced pathway (13 min + 2 min for Q&A)
Annika Lintala: Reptarenavirus Co- and Superinfection in Cell Culture Sheds Light on the S and L Segment Accumulation in Captive Snakes
Rommel Iheozor-Ejiofor: Neutralizing Antibody Titers in Hospitalized Patients with Acute Puumala Orthohantavirus Infection Do Not Associate with Disease Severity
Vesa Aho: HSV-1 capsid motion reveals infection-induced changes in the intranuclear environment
Mert Erdin: Strain-specific in silico analysis of Dobrava-Belgrade orthohantavirus Gn ectodomain DAF/CD55 interaction
Simon Leclerc: Herpesvirus-induced changes in the structure and function of mitochondria
Sini Huuskonen: Characterizing the viral-host interaction changes of SARS-CoV-2 variants via BioID-MS
Pamela Österlund: Antiviral evasion strategies of avian influenza viruses
15:00 – 15:10 Closing remarks